Pin1 modulates the type 1 immune response

PLoS ONE

Volumn 2, Issue 2, 2007, Pages

  Esnault, Stephane ^a,b   Braun, Ruedi K ^a   Shen, Zhong Jian ^a,b   Xiang, Zhuzai ^a   Heninger, Erika ^a   Love, Robert B ^a   Sandor, Matyas ^a   Malter, James S ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; INTERLEUKIN 4; JUGLONE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PEPTIDYLPROLYL ISOMERASE PIN1; CXCL10 PROTEIN, MOUSE; CXCL10 PROTEIN, RAT; CYCLOSPORIN; NAPHTHOQUINONE; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PAPIN PROTEIN, RAT; PEPTIDYLPROLYL ISOMERASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHRONIC GRAFT REJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MONOTHERAPY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY T LYMPHOCYTE; RNA TRANSCRIPTION; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; ALLOTRANSPLANTATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; FISCHER 344 RAT; GENETIC TRANSCRIPTION; GENETICS; GRAFT REJECTION; IMMUNOLOGY; MOUSE MUTANT; PHYSIOLOGY; RAT; RNA PROCESSING; RNA STABILITY; TH1 CELL; WISTAR KYOTO RAT;

RATTUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CHEMOKINE CXCL10; CYCLOSPORINE; GRAFT REJECTION; INTERFERON-GAMMA; INTERLEUKIN-2; LUNG TRANSPLANTATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NAPHTHOQUINONES; PEPTIDYLPROLYL ISOMERASE; RATS; RATS, INBRED F344; RATS, INBRED WKY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; RNA, MESSENGER; TH1 CELLS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548693416     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000226     Document Type: Article

References (35)

1. Haring JS, Corbin GA, Harty JT (2005) Dynamic regulation of IFN-gamma signaling in antigen-specific CD8+ T cells responding to infection. J. Immunol. 174: 6791-6802.
2. Yi T, Cuchara L, Wang Y, Koh KP, Ranjbaran H, et al. (2006) Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma. Transplantation 81: 559-566.
3. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
4. Lindstein T, June CH, Ledbetter JA, Stella G, Thompson CB (1989) Regulation of lymphokine messenger RNA stability by a surface-mediated T cellactivation pathway. Science 244: 339-343.
5. Mavropoulos A, Sully G, Cope AP, Clark AR (2005) Stabilization of IFN-gamma mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells. Blood 105: 282-288.
6. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, et al. (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-8015.
7. Wulf GM, Liou YC, Ryo A, Lee SW, Lu KP (2002) Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 277: 47976-47979.
8. Zhou XZ, Kops O, Werner A, Lu PJ, Shen M, et al. (2000) Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6: 873-883.
9. Lu KP, Hanes SD, Hunter T (1996) A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547.
10. Wulf GM, Ryo A, Wulf GG, Lee SW, Niu T, et al. (2001) Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20: 3459-3472.
11. Ayala G, Wang D, Wulf G, Frolov A, Li R, et al. (2003) The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63: 6244-6251.
12. Shen ZJ, Esnault S, Malter JS (2005) The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nat. Immunol. 6: 1280-1287.
13. Esnault S, Shen ZJ, Whitesel E, Malter JS (2006) The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J. Immunol. 177: 6999-7006.
14. Shaw G, Kamen R (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667.
15. Bakheet T, Frevel M, Williams BR, Greer W, Khabar KS (2001) ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res. 29: 246-254.
16. Lu KP (2004) Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29: 200-209.
17. Hennig L, Christner C, Kipping M, Schelbert B, Rucknagel KP, et al. (1998) Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37: 5953-5960.
18. Haque MA, Mizobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, et al. (2002) Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J. Immunol. 169: 1542-1549.
19. Sekine Y, Bowen LK, Heidler KM, Van Rooijen N, Brown JW, et al. (1997) Role of passenger leukocytes in allograft rejection: effect of depletion of donor alveolar macrophages on the local production of TNF-alpha, T helper 1/T helper 2 cytokines, IgG subclasses, and pathology in a rat model of lung transplantation. J. Immunol. 159: 4084-4093.
20. Zhao DX, Hu Y, Miller GG, Luster AD, Mitchell RN, et al. (2002) Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J. Immunol. 169: 1556-1560.
21. Hauser IA, Spiegle S, Kiss E, Gauer S, Sichler O, et al. (2005) Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J. Am. Soc. Nephrol. 16: 1849-1858.
22. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N (2001) Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193: 975-980.
23. Nickel P, Presber F, Bold G, Biti D, Schonemann C, et al. (2004) Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78: 1640-1646.
24. Reinders ME, Sho M, Izawa A, Wang P, Mukhopadhyay D, et al. (2003) Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J. Clin. Invest. 112: 1655-1665.
25. Mizobuchi T, Yasufuku K, Zheng Y, Haque MA, Heidler KM, et al. (2003) Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J. Immunol. 171: 1140-1147.
26. Duncan MD, Wilkes DS (2005) Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc. Am. Thorac. Soc. 2: 449-455.
27. Pierog J, Gazdhar A, Stammberger U, Gugger M, Hyde S, et al. (2005) Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation. Eur. J. Cardiothorac. Surg. 27: 1030-1035.
28. Gothel SF, Marahiel MA (1999) Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol. Life Sci. 55: 423-436.
29. Chao SH, Greenleaf AL, Price DH (2001) Juglone, an inhibitor of the peptidylprolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 29: 767-773.
30. Agostini C, Calabrese F, Rea F, Facco M, Tosoni A, et al. (2001) CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am. J. Pathol. 158: 1703-1711.
31. Hancock WW, Lu B, Gao W, Csizmadia V, Faia K, et al. (2000) Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
32. van Besouw NM, Zuijderwijk JM, Vaessen LM, Balk AH, Maat AP, et al. (2005) The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin. Exp. Immunol. 141: 534-540.
33. Kitade H, Kawai M, Koshiba T, Giulietti A, Overbergh L, et al. (2004) Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation 78: 1747-1755.
34. Hodge G, Hodge S, Reynolds P, Holmes M (2005) Intracellular cytokines in blood T cells in lung transplant patients-a more relevant indicator of immunosuppression than drug levels. Clin. Exp. Immunol. 139: 159-164.
35. Nickel P, Presber F, Bold G, Biti D, Schonemann C, et al. (2004) Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 78: 1640-1646.